Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03169816
Brief Title: Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder

First Submitted : May 25, 2017
First Submitted that Met QC Criteria : May 25, 2017
First Posted : May 30, 2017

Results First Submitted : August 25, 2020
Results First Submitted that Met QC Criteria : September 10, 2020
Results First Posted : October 5, 2020

Last Update Submitted that Met QC Criteria : September 10, 2020
Last Update Posted : October 5, 2020